Aisling Capital Management as of Sept. 30, 2024
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 16 positions in its portfolio as reported in the September 2024 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 59.2 | $155M | 6.1M | 25.46 | |
| Verona Pharma Sponsored Ads (VRNA) | 12.3 | $32M | 1.1M | 28.77 | |
| Syndax Pharmaceuticals (SNDX) | 7.6 | $20M | 1.0M | 19.25 | |
| Bicara Therapeutics (BCAX) | 5.6 | $15M | 569k | 25.47 | |
| Biomea Fusion (BMEA) | 3.1 | $8.1M | 799k | 10.10 | |
| Monte Rosa Therapeutics (GLUE) | 3.0 | $7.8M | 1.5M | 5.30 | |
| Compass Pathways Sponsored Ads (CMPS) | 2.3 | $6.1M | 965k | 6.30 | |
| Nuvation Bio Com Cl A (NUVB) | 2.2 | $5.8M | 2.5M | 2.29 | |
| Poseida Therapeutics I (PSTX) | 1.1 | $3.0M | 1.0M | 2.86 | |
| Tectonic Therapeutic (TECX) | 1.0 | $2.5M | 84k | 30.30 | |
| CalciMedica Com New (CALC) | 0.9 | $2.3M | 521k | 4.43 | |
| Elevation Oncology (ELEV) | 0.7 | $1.7M | 2.8M | 0.60 | |
| Reneo Pharmaceuticals (RPHM) | 0.6 | $1.5M | 886k | 1.70 | |
| Marker Therapeutics Com New (MRKR) | 0.3 | $886k | 314k | 2.82 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $500k | 435k | 1.15 | |
| Viracta Therapeutics (VIRX) | 0.0 | $66k | 289k | 0.23 |
